Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-9.97 Mil
% of Total Estimate Gain
-38.49%

SILVERARC CAPITAL MANAGEMENT, LLC's Pliant Therapeutics Inc Holding Summary

As of 2025-03-31, SILVERARC CAPITAL MANAGEMENT, LLC held - shares of Pliant Therapeutics Inc(PLRX), totaling N/A. This investment constitutes 0% of their stock portfolio, and SILVERARC CAPITAL MANAGEMENT, LLC now holds 0% of the outstanding Pliant Therapeutics Inc(PLRX) stock.

The initial trade took place in 2022Q3. And since then SILVERARC CAPITAL MANAGEMENT, LLC has made 6 purchases of PLRX, at an average price of $14.78, for a total of 1.75 Mil shares. In addition, there have been 4 sales at an average price of $9.09 for 1.75 Mil shares. Based on historical transaction data and PLRX's current price of $1.43, SILVERARC CAPITAL MANAGEMENT, LLC's estimated gain on his PLRX holdings is $-9.97 Mil, reflecting a -38.49% gain to date.

SILVERARC CAPITAL MANAGEMENT, LLC PLRX ($1.43) Holding Chart

SILVERARC CAPITAL MANAGEMENT, LLC PLRX ($1.43) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1